Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

584 Articles

Jon C. Ogg | Jan 9, 2012 at 11:11 AM EST

Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)

You know how stocks sometimes react to news on peers… Today we are again seeing a run in the world…

Paul Ausick | Jan 9, 2012 at 8:06 AM EST

Inhibitex Stock up 150% in Pre-Market (BMY, INHX)

Bristol-Myers Squibb (NYSE: BMY) will pay $2.5 billion in cash (a 163% premium to Friday’s closing price) for hepatitis C…

Douglas A. McIntyre | Jan 9, 2012 at 6:47 AM EST

What’s Important in the Financial World (1/9/2012) Chevy Volt Revivial, M&A Monday

Deal makers were busy over the weekend. Strategic considerations were more the driver of activity than an improved economy, however.…

Douglas A. McIntyre | Jan 9, 2012 at 6:46 AM EST

Media Digest (1/9/2012) Reuters, WSJ, NYT, FT, Bloomberg

http://platform.twitter.com/widgets/hub.1324331373.html The U.S. may start legal proceedings against Swiss financial firm Wegelin & Co. based on beliefs that it helped…

Douglas A. McIntyre | Jan 8, 2012 at 5:07 PM EST

Bristol-Myers Squibb (BMY) To Buy Inhibitex (IHNX)

Bristol-Myers (NYSE: BMY) will buy Inhibitex (NASDAQ: IHNX) for $26 a share about 2.5x what the smaller company’s shares traded…

Douglas A. McIntyre | Nov 30, 2011 at 6:20 AM EST

Media Digest (11/30/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

The EU continues to work on its bailout fund and may ask the IMF for help. (Reuters) American Airlines parent…

Paul Ausick | Nov 21, 2011 at 1:47 PM EST

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1…

Paul Ausick | Oct 27, 2011 at 4:11 PM EDT

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

The DJIA jumped above 12,000 in the opening minutes of trading this morning and had topped 12,200 by mid-afternoon. European…

Paul Ausick | Oct 20, 2011 at 10:58 AM EDT

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…

Jon C. Ogg | Oct 19, 2011 at 10:18 AM EDT

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public. So what…

Jon C. Ogg | Oct 12, 2011 at 2:10 PM EDT

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…

Douglas A. McIntyre | Oct 6, 2011 at 7:27 PM EDT

America’s Recession-Proof Companies

With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there…

Jon C. Ogg | Sep 22, 2011 at 8:14 AM EDT

Top Analyst Upgrades & Downgrades (AMSF, BMY, BRCM, CBST, HOV, INTC, JNJ, KBH, LEN, LULU, MAKO, NFLX, ASGN, OKS, TSLA, TWX, YHOO, YOKU)

Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | Sep 19, 2011 at 8:19 AM EDT

Top Analyst Upgrades & Downgrades (AMAT, CAR, BMY, BRCM, CTRN, CL, ENB, HUN, LRCX, MU, PIR, RENN, TEF)

Jon OggThese are some of this Monday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…

Jon C. Ogg | Aug 29, 2011 at 12:39 PM EDT

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in…

1 … 31 32 33 34 35 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)

Inhibitex Stock up 150% in Pre-Market (BMY, INHX)

What’s Important in the Financial World (1/9/2012) Chevy Volt Revivial, M&A Monday

Media Digest (1/9/2012) Reuters, WSJ, NYT, FT, Bloomberg

Bristol-Myers Squibb (BMY) To Buy Inhibitex (IHNX)

Media Digest (11/30/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

America’s Recession-Proof Companies

Top Analyst Upgrades & Downgrades (AMSF, BMY, BRCM, CBST, HOV, INTC, JNJ, KBH, LEN, LULU, MAKO, NFLX, ASGN, OKS, TSLA, TWX, YHOO, YOKU)

Top Analyst Upgrades & Downgrades (AMAT, CAR, BMY, BRCM, CTRN, CL, ENB, HUN, LRCX, MU, PIR, RENN, TEF)

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Nvidia’s CEO Sees Marvell Becoming the Next $1 Trillion Company. Shares Gained Another 5% Today.

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)

Inhibitex Stock up 150% in Pre-Market (BMY, INHX)

What’s Important in the Financial World (1/9/2012) Chevy Volt Revivial, M&A Monday

Media Digest (1/9/2012) Reuters, WSJ, NYT, FT, Bloomberg

Bristol-Myers Squibb (BMY) To Buy Inhibitex (IHNX)

Media Digest (11/30/2011) Reuters, WSJ, NYTimes, FT, Bloomberg

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

24/7 Closing Bell (F, NFLX, ITRI, V, RRC, PG, CL, XOM, OXY, ABX, JCI, BMY, MO, QUIK, KELYB, LDK, CENX, MDR, AVP)

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

America’s Recession-Proof Companies

Top Analyst Upgrades & Downgrades (AMSF, BMY, BRCM, CBST, HOV, INTC, JNJ, KBH, LEN, LULU, MAKO, NFLX, ASGN, OKS, TSLA, TWX, YHOO, YOKU)

Top Analyst Upgrades & Downgrades (AMAT, CAR, BMY, BRCM, CTRN, CL, ENB, HUN, LRCX, MU, PIR, RENN, TEF)

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Nvidia’s CEO Sees Marvell Becoming the Next $1 Trillion Company. Shares Gained Another 5% Today.

Featured Reads

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life